QUEST DIAGNOSTICS INC 4

Director Timothy L. Main acquired 21 shares of Quest Diagnostics Inc. common stock via a dividend reinvestment plan, bringing his direct holdings to 22,460 shares.

On July 22, 2026, director Timothy L. Main reported the acquisition of 21 shares of Quest Diagnostics Inc. common stock at an implied price of $206.81 per share, totaling approximately $4,343, through a dividend reinvestment plan administered by his broker. This routine, elective early-reported transaction (eligible for deferred Form 5 reporting under Rule 16a-6) increased his directly held position to 22,460 shares, while he also reports an additional 5,000 shares held indirectly in a trust. Using the current market price of about $230.39, his directly owned stake is now valued at roughly $5.17 million, and his indirect trust holdings at about $1.15 million, underscoring a substantial ongoing ownership position rather than a discretionary open-market trade.

Filing Facts

CIK

1022079

Ticker

DGX

Form

4

Source Type

sec

Accession

0001022079-26-000082

Alert Tier

4